GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » EV-to-EBITDA

CBIH (Cannabis Bioscience International Holdings) EV-to-EBITDA : -21.35 (As of Dec. 14, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cannabis Bioscience International Holdings's enterprise value is $6.73 Mil. Cannabis Bioscience International Holdings's EBITDA for the trailing twelve months (TTM) ended in Aug. 2024 was $-0.32 Mil. Therefore, Cannabis Bioscience International Holdings's EV-to-EBITDA for today is -21.35.

The historical rank and industry rank for Cannabis Bioscience International Holdings's EV-to-EBITDA or its related term are showing as below:

CBIH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -73.1   Med: 0.41   Max: 0.48
Current: -21.35

During the past 7 years, the highest EV-to-EBITDA of Cannabis Bioscience International Holdings was 0.48. The lowest was -73.10. And the median was 0.41.

CBIH's EV-to-EBITDA is ranked worse than
100% of 718 companies
in the Drug Manufacturers industry
Industry Median: 14.21 vs CBIH: -21.35

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-14), Cannabis Bioscience International Holdings's stock price is $0.0006. Cannabis Bioscience International Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 was $0.000. Therefore, Cannabis Bioscience International Holdings's PE Ratio (TTM) for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Cannabis Bioscience International Holdings EV-to-EBITDA Historical Data

The historical data trend for Cannabis Bioscience International Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings EV-to-EBITDA Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11 May23 May24
EV-to-EBITDA
Get a 7-Day Free Trial - -3.77 1.00 -5.98 -13.47

Cannabis Bioscience International Holdings Quarterly Data
May09 Aug09 Nov09 Feb10 May10 Aug10 Nov10 Feb11 May11 Aug11 Nov11 Feb12 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.67 -12.12 -13.11 -13.47 -29.73

Competitive Comparison of Cannabis Bioscience International Holdings's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's EV-to-EBITDA falls into.



Cannabis Bioscience International Holdings EV-to-EBITDA Calculation

Cannabis Bioscience International Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=6.726/-0.315
=-21.35

Cannabis Bioscience International Holdings's current Enterprise Value is $6.73 Mil.
Cannabis Bioscience International Holdings's EBITDA for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Cannabis Bioscience International Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0006/0.000
=N/A

Cannabis Bioscience International Holdings's share price for today is $0.0006.
Cannabis Bioscience International Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Cannabis Bioscience International Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 435N, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The company provides services in therapeutic areas of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. It offered concierge medicine at an affordable price through a membership-based model through its wholly-owned subsidiary.